These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

940 related articles for article (PubMed ID: 29168933)

  • 1. Role of chemotherapy and targeted therapy in early-stage non-small cell lung cancer.
    Nagasaka M; Gadgeel SM
    Expert Rev Anticancer Ther; 2018 Jan; 18(1):63-70. PubMed ID: 29168933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Chemotherapy and Targeted Therapy in Early-Stage Non-Small Cell Lung Cancer.
    Gadgeel SM
    Am Soc Clin Oncol Educ Book; 2017; 37():630-639. PubMed ID: 28561669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic and targeted therapies for early-stage lung cancer.
    Byron E; Pinder-Schenck M
    Cancer Control; 2014 Jan; 21(1):21-31. PubMed ID: 24357738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The emerging perioperative treatment paradigm for non-small cell lung cancer: a narrative review.
    Christopoulos P
    Chin Clin Oncol; 2024 Feb; 13(1):12. PubMed ID: 38372058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant Therapy of Resected Non-small Cell Lung Cancer: can We Move Forward?
    Buffoni L; Vavalà T; Novello S
    Curr Treat Options Oncol; 2016 Oct; 17(10):54. PubMed ID: 27523606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postoperative adjuvant therapy for resectable early non-small cell lung cancer: A protocol for a systematic review and meta-analysis.
    Chai T; Zhang P; Lin Y; Zhang Z; Lin W; Kang M; Lin J
    Medicine (Baltimore); 2019 Jul; 98(30):e16468. PubMed ID: 31348250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups.
    Strauss GM; Herndon JE; Maddaus MA; Johnstone DW; Johnson EA; Harpole DH; Gillenwater HH; Watson DM; Sugarbaker DJ; Schilsky RL; Vokes EE; Green MR
    J Clin Oncol; 2008 Nov; 26(31):5043-51. PubMed ID: 18809614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidermal growth factor receptor tyrosine kinase inhibitors in early-stage nonsmall cell lung cancer.
    Spaans JN; Goss GD
    Curr Opin Oncol; 2015 Mar; 27(2):102-7. PubMed ID: 25611026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient subsets benefiting from adjuvant therapy following surgical resection of non-small cell lung cancer.
    Johnson BE; Rabin MS
    Clin Cancer Res; 2005 Jul; 11(13 Pt 2):5022s-5026s. PubMed ID: 16000607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resectable non-small cell lung cancer Adjuvant chemotherapy: slightly longer survival.
    Prescrire Int; 2016 Dec; 25(177):299-301. PubMed ID: 30758927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Designing a definitive trial for adjuvant targeted therapy in genotype defined lung cancer: the ALCHEMIST trials.
    Alden RS; Mandrekar SJ; Oxnard GR
    Chin Clin Oncol; 2015 Sep; 4(3):37. PubMed ID: 26408304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of the MAGE-A3 cancer immunotherapeutic as adjuvant therapy in patients with resected MAGE-A3-positive non-small-cell lung cancer (MAGRIT): a randomised, double-blind, placebo-controlled, phase 3 trial.
    Vansteenkiste JF; Cho BC; Vanakesa T; De Pas T; Zielinski M; Kim MS; Jassem J; Yoshimura M; Dahabreh J; Nakayama H; Havel L; Kondo H; Mitsudomi T; Zarogoulidis K; Gladkov OA; Udud K; Tada H; Hoffman H; Bugge A; Taylor P; Gonzalez EE; Liao ML; He J; Pujol JL; Louahed J; Debois M; Brichard V; Debruyne C; Therasse P; Altorki N
    Lancet Oncol; 2016 Jun; 17(6):822-835. PubMed ID: 27132212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoadjuvant chemotherapy in stage III NSCLC.
    Allen J; Jahanzeb M
    J Natl Compr Canc Netw; 2008 Mar; 6(3):285-93. PubMed ID: 18377847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant chemotherapy for surgically resected non-small cell lung cancer.
    Heon S; Johnson BE
    J Thorac Cardiovasc Surg; 2012 Sep; 144(3):S39-42. PubMed ID: 22502967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The rationale for adjuvant chemotherapy in stage I non-small cell lung cancer.
    Horn L; Sandler AB; Putnam JB; Johnson DH
    J Thorac Oncol; 2007 May; 2(5):377-83. PubMed ID: 17473651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early-stage non-small-cell lung cancer: current perspectives in combined-modality therapy.
    Bunn PA
    Clin Lung Cancer; 2004 Sep; 6(2):85-98. PubMed ID: 15476594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer Care Ontario and American Society of Clinical Oncology adjuvant chemotherapy and adjuvant radiation therapy for stages I-IIIA resectable non small-cell lung cancer guideline.
    Pisters KM; Evans WK; Azzoli CG; Kris MG; Smith CA; Desch CE; Somerfield MR; Brouwers MC; Darling G; Ellis PM; Gaspar LE; Pass HI; Spigel DR; Strawn JR; Ung YC; Shepherd FA; ;
    J Clin Oncol; 2007 Dec; 25(34):5506-18. PubMed ID: 17954710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Perioperative therapies in surgical non N2 non-small cell lung cancer].
    Ruppert AM; Lavolé A; Assouad J; Cadranel J; Wislez M
    Bull Cancer; 2017 Jan; 104(1):79-85. PubMed ID: 27912893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postoperative Adjuvant Systemic Therapy in Completely Resected Non-Small-Cell Lung Cancer: A Systematic Review.
    Bradbury P; Sivajohanathan D; Chan A; Kulkarni S; Ung Y; Ellis PM
    Clin Lung Cancer; 2017 May; 18(3):259-273.e8. PubMed ID: 28162945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of chemotherapy in stages I to III non-small cell lung cancer.
    Strauss GM
    Chest; 1999 Dec; 116(6 Suppl):509S-516S. PubMed ID: 10619521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.